New federal guidance from the CDC aims to tighten oversight of ABA therapy for autistic children, signalling a shift towards stricter billing and reduced telehealth reliance amid soaring costs and concerns over service quality.
Children receiving applied behaviour analysis through Medicaid may soon face a very different system of care. According to STAT, the Centres for Medicare and Medicaid Services has issued new guidance aimed at tightening oversight of ABA, the therapy most commonly used for autistic children, with a particular emphasis on measurable outcomes, billing scrutiny and a reduced reliance on telehealth.
The move reflects growing unease inside Medicaid over the sharp rise in ABA spending. STAT reported that spending in Medicaid and CHIP increased by 421% between 2021 and 2025, while some state agencies have paid out far more than expected. At the same time, critics have complained of inflated billing and questionable services, even as other families say access remains poor because providers are overburdened and waiting lists are long.
The CMS toolkit is not binding, but it is likely to shape state policy over time. As STAT noted, the document urges states to “limit” virtual care as the main way ABA is delivered, with officials increasingly alert to possible fraud risks. That stance marks a shift from the broader telehealth push seen during the pandemic, when CMS and Medicaid promoted remote services to widen access.
The guidance also sits within a longer-running policy debate over what Medicaid must cover. CMS has previously said it does not mandate ABA for children with autism, while making clear that states still have obligations under early and periodic screening, diagnostic and treatment rules to provide medically necessary care. Recent state-level changes, including Indiana’s new ABA rules that took effect on 1 April 2026, suggest the federal signal is already beginning to filter through to programme design, reimbursement and provider expectations.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
